secwatch.observer — SEC 8-K summary
======================================

Issuer:     IRADIMED CORP (IRMD)
CIK:        0001325618
Form:       8-K/A
Filed at:   2026-08-18T18:03:52+00:00
Accession:  0001628280-26-057617
Event type: earnings
Sentiment:  neutral
Materiality: 0.50
Item codes: 2.02, 9.01, 8.01
LLM model:  deepseek-v4-flash:cloud@v2

Iradimed Q2 revenue flat at $20.5M, EPS down 9% to $0.41; reaffirms FY guidance
-------------------------------------------------------------------------------

- Q2 revenue $20.5M, up 0.5% YoY; GAAP EPS $0.41, down 9%; non-GAAP EPS $0.46, down 7%.
- Net income $5.2M, down 10% YoY; gross margin 74% vs 78% prior year.
- Declares $0.20/share quarterly dividend, payable Aug 28, 2026, record Aug 14, 2026.
- Reaffirms FY2026 guidance: revenue $91-96M, GAAP EPS $1.90-2.05, non-GAAP $2.09-2.24.
- New 3870 MR IV pump launch underway; >70% of new pump orders for quad stack configuration.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1325618/000162828026057617/0001628280-26-057617-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1325618/000162828026057617/irmd-20260731.htm
  HTML page:      https://secwatch.observer/filing/0001628280-26-057617

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer